Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling
Authors
Keywords
-
Journal
Future Oncology
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2018-05-11
DOI
10.2217/fon-2018-0210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes
- (2017) Nathan J. Schloemer et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Prevention of cardiotoxicity among survivors of childhood cancer
- (2016) Kelley K. Hutchins et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
- (2016) Barbara L. Asselin et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89)
- (2015) Vered Shkalim-Zemer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiac complications in childhood cancer survivors treated with anthracyclines
- (2015) Vivian I. Franco et al. CARDIOLOGY IN THE YOUNG
- Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group
- (2015) Eric J. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer
- (2015) Elizabeth A.M. Feijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis
- (2015) Furqan Shaikh et al. JNCI-Journal of the National Cancer Institute
- Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
- (2015) Cindy L. Schwartz et al. PEDIATRIC BLOOD & CANCER
- Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia
- (2015) M Krajinovic et al. PHARMACOGENOMICS JOURNAL
- Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis
- (2015) Furqan Shaikh et al. JNCI-Journal of the National Cancer Institute
- Dexrazoxane
- (2014) Vivian Wu Journal of Pediatric Oncology Nursing
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients
- (2014) Alix E. Seif et al. PEDIATRIC BLOOD & CANCER
- Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy
- (2014) Kasey Leger et al. PEDIATRIC BLOOD & CANCER
- Oxaliplatin and Doxorubicin for Relapsed or Refractory High-Risk Neuroblastoma
- (2014) Hung C. Tran et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
- (2013) Kashif Kalam et al. EUROPEAN JOURNAL OF CANCER
- A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
- (2013) Leo Mascarenhas et al. PEDIATRIC BLOOD & CANCER
- Oxaliplatin-related thrombocytopenia
- (2012) D. L. Jardim et al. ANNALS OF ONCOLOGY
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Cardioprotective effect of early dexrazoxane use in anthracycline treated pediatric patients
- (2012) Minkyoung Kang et al. JOURNAL OF CHEMOTHERAPY
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: Analysis of a national cohort of patients in the pediatric health information systems database
- (2012) Dana M. Walker et al. PEDIATRIC BLOOD & CANCER
- Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: A report from the Children's Oncology Group
- (2012) Cameron K. Tebbi et al. PEDIATRIC BLOOD & CANCER
- Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)
- (2011) B. L. Asselin et al. BLOOD
- Pegylated Liposomal Doxorubicin
- (2011) Sean T. Duggan et al. DRUGS
- The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
- (2011) Lynda M. Vrooman et al. EUROPEAN JOURNAL OF CANCER
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- Childhood Cancer Survivors: Transition to Adult-Focused Risk-Based Care
- (2010) T. O. Henderson et al. PEDIATRICS
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
- (2008) Martee L. Hensley et al. JOURNAL OF CLINICAL ONCOLOGY
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
- (2008) A. C. Mertens et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search